Skip to content

    Arcutis Biotherapeutics (ARQT) stock price & financials

    View ARQT earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+51.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $44.76M
    $71.36M
    $65.85M
    $81.50M
    $99.22M
    +121.7%
    $129.50M
    +81.5%
    $105.40M
    +60.1%
    $129.86M
    +59.3%
    Strengthening
    Operating Profit
    -$39.07M
    -$7.63M
    -$24.53M
    -$14.61M
    $8.53M
    $18.39M
    -$9.09M
    +62.9%
    $16.43M
    Strengthening
    Net Profit
    -$41.54M
    -$10.79M
    -$25.06M
    -$15.89M
    $7.41M
    $17.39M
    -$11.29M
    +54.9%
    $15.01M
    Strengthening
    EPS
    $-0.33
    $-0.20
    $-0.13
    $0.06
    $-0.09
    +55.0%
    $0.11
    Strengthening
    Other Income
    -$933.0K
    -$1.28M
    -37.6%
    Weakening
    Interest
    $6.65M
    $5.55M
    $2.98M
    $3.03M
    $3.07M
    -53.8%
    $3.00M
    -45.9%
    $4.37M
    +46.5%
    $3.41M
    +12.4%
    Strengthening
    Depreciation
    Profit before Tax
    MarginsOPM
    -87.3%
    -10.7%
    -37.3%
    -17.9%
    8.6%
    14.2%
    -8.6%
    +76.9%
    12.7%
    Strengthening
    Tax
    ReturnsROIC
    3.7%
    1.0%
    2.2%
    1.4%
    -0.7%
    -117.8%
    -1.5%
    -261.2%
    1.0%
    -54.9%
    -1.3%
    -194.5%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$39.39M$63.34M$65.08M$96.45M$53.64M$88.39M$71.33M$42.91M$34.12M
    Short-Term Investments
    Total Current Assets$106.47M$292.83M$402.77M$437.41M$330.43M$335.82M$411.23M$467.67M
    Net PP&E$491.0K$5.37M$5.30M$4.60M$3.90M$2.99M$5.51M$5.13M
    Goodwill
    Intangibles$0$7.19M$6.44M$9.48M$14.81M$13.69M
    Total Assets$107.01M$298.27M$408.15M$449.27M$341.37M$348.89M$432.97M$488.54M
    LiabilitiesTotal Current Liabilities$5.24M$22.60M$33.33M$37.81M$46.67M$81.01M$129.84M$160.34M
    Short-Term Debt$0$0$1.00M$6.95M
    Long-Term Debt$0$72.35M$197.77M$201.80M$107.20M$107.96M$101.95M
    Long-Term Leases$129.0K$4.96M$4.77M$4.12M$3.38M$2.56M$5.27M$5.24M
    Total Liabilities$5.55M$27.65M$110.47M$239.69M$252.70M$191.35M$243.49M$267.96M
    EquityCommon Stock & APIC$0$4.0K$5.0K$6.0K$9.0K$12.0K$12.0K$12.0K
    Retained Earnings-$66.27M-$201.95M-$408.31M-$719.76M-$981.90M-$1.12B-$1.14B-$1.13B
    Total Equity-$23.99M-$65.03M$270.62M$297.68M$209.58M$88.67M$157.54M$189.48M$220.58M
    HighlightsNet Cash / (Debt)-$113.40M-$35.87M-$66.05M-$74.78M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$14.09M-$42.84M-$113.03M-$174.63M-$257.71M-$247.06M-$112.16M-$5.63M$39.31M
    Cash from Investing-$11.53M-$26.32M-$181.82M-$75.95M-$87.20M$180.23M$28.82M-$30.25M-$85.98M
    Cash from Financing$61.59M$93.10M$298.14M$281.95M$301.80M$101.32M$66.20M$6.97M$8.26M
    SummaryCapital Expenditure$0-$295.0K-$321.0K-$995.0K-$333.0K-$428.0K-$143.0K-$686.0K-$158.0K
    Free Cash Flow-$14.09M-$43.13M-$113.35M-$175.62M-$258.05M-$247.49M-$112.30M-$6.31M$39.15M
    FCF Margin-7000.8%-415.2%-57.1%-1.7%8.4%

    Ratios